CEFPODOXIME ZENTIVA for children and for infants 40 mg/5 ml, granules for oral suspension bottle, 16.7 g
Active ingredients: Cefpodoxime, Cefpodoxime proxetil
Commercialized according to BDPMDispensing in France: Prescription only
Granules for oral suspensionbottle, 16.7 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFPODOXIME ZENTIVA ENFANTS ET NOURRISSONS 40 mg/5 ml, granulés pour suspension buvable
- Pharmaceutical form
- granulés pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre de 16,7 g avec seringue(s) pour administration orale
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Jun 2008
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64384688CIP73360377CIP133400933603779Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CEFPODOXIMEgranulés | 4,800 g · 100 g | FT |
| CEFPODOXIME PROXÉTILgranulés | 6,261 g · 100 g | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.